Fitch Rates Swedish Covenant Hospital (IL) Revs 'BBB+'; Outlook Stable

CHICAGO--()--Fitch Ratings has assigned a 'BBB+' rating to the following Illinois Finance Authority revenue bonds, issued on behalf of Swedish Covenant Hospital (SCH):

--$107.1 million revenue bonds, series 2016.

The series 2016 bonds are being issued as fixed-rate, to be used to refund SCH's series 2010A and 2010C bonds outstanding, fund capital expenditures, and pay costs of issuance. The series 2016 bonds are expected to price via negotiated sale the week of Oct. 31.

In addition, Fitch affirms the following:

--$49.5 million variable-rate demand revenue bonds, series 2008A at 'BBB+';

--$92 million revenue bonds, series 2010A at 'BBB+'.

The Rating Outlook is Stable.

SECURITY

Pledge of obligated group (OG) gross revenues is expected to secure the series 2016 bonds. Series 2010 bonds are further secured by a debt service reserve and mortgage.

KEY RATING DRIVERS

MANAGEABLE DEBT BURDEN: The series 2016 bonds will not add net debt to SCH's balance sheet, and its overall debt burden is expected to continue to moderate over time. Maximum annual debt service (MADS) will decline slightly to an estimated $11.8 million, which represented 3.7% of interim 2016 operating revenues relative to the 'BBB' median of 3.6%, and was covered 2.7x from operating EBITDA relative to the 'BBB' median of 2.6x.

STEADY PROFITABILITY: SCH's operating profitability is consistent with expectations, generating a 10.1% operating EBITDA margin through the nine-month interim period ended June 30, 2016. Solid results show improved operating efficiencies and optimization of a now stabilized medical staff. Profitability is expected to decline in fiscal 2017 but remain solid for the rating level with an adequate 8% operating EBITDA margin budgeted (16% OG operating EBITDA budgeted).

HEALTHY LIQUIDITY: SCH's liquidity remains solid, though increasing capital plans over the near term may slow continued growth somewhat. At June 30, 2016, unrestricted cash and investments was $149.6 million, which translated to 185.1 days cash on hand (DCOH) 83% cash to debt, and a 12.7x cushion ratio. These are comparable to Fitch's respective 'BBB' category medians of 161.2 DCOH, 11.7x cushion, and 90.8% cash-to-debt, and have improved consistently year-over-year. Fitch believes this level of liquidity serves as an important buffer to mitigate the risks of SCH's small revenue base.

MIXED SERVICE AREA: The greater Chicago market is competitive, and SCH's service area in northern Cook County houses several sizeable competitors with comparable services and has challenging demographic and economic indicators. SCH has maintained its 12-zip code service area inpatient market position over the past few years at 18.6% share in 2015 (versus 18.9% share in 2014 and 2013). Fitch expects heightened competitive activity for a limited clinical volume base to remain an ongoing credit challenge, as well as SCH's unfavorable payor mix and exposure to fluctuations in supplemental funding.

RATING SENSITIVITIES

STEADY OPERATING RESULTS: Rating stability is supported by the expectation that Swedish Covenant Hospital (SCH) will generate operating results that are consistent with budget expectations. Specifically, management is budgeting for a consolidated operating EBIDA margin of 8% in fiscal 2017 and obligated group operating EBITDA margin of 16%. Further, balance sheet strength is expected to remain stable and commensurate with the rating.

CREDIT PROFILE

Located approximately 10 miles north of Chicago city center in the Ravenswood community, SCH is a 312-bed acute care hospital which was founded by the Evangelical Covenant Church in 1886. The sole corporate member of SCH is Covenant Ministries of Benevolence, which is a subordinate entity of the Church. Today the organization also includes the Swedish Covenant Medical Group (SCMG), the captive insurance company Swedish Covenant Insurance Company (SCIC), several ambulatory care sites, and a Foundation.

Fitch uses consolidated financials in its analysis. The hospital is the sole member of the OG, which represents approximately 89% of net revenues and 98% of total assets of the consolidated entity. Total operating revenues were $319.3 million in fiscal 2015 (audited, Sept. 30 year end).

SOLID OPERATIONS

SCH's efforts in 2014 and 2015 to implement strategic ambulatory growth, as well as to optimize its medical staff helped produce solid results in fiscal 2015 and well into 2016. Through the nine-month interim period ended June 30, 2016, SCH generated a 10.1% operating EBITDA margin and 2.7x coverage of MADS, following fiscal 2015's 11% operating EBITDA margin and 3x MADS coverage.

Capital outlays have been modest over the past three fiscal years, and are expected to grow over the near term as SCH undertakes an emergency room renovation/expansion (fall 2016-spring 2018) and implements an electronic health record system upgrade in mid-2017. While approximately $10 million in bond proceeds from the series 2016 transaction will help fund capital needs, SCH will also utilize cash flow, philanthropy, and available funds from the Tax Increment Financing (TIF) grant awarded to SCH.

CHALLENGING MARKET

SCH's service area is challenging, due to the presence of several sizeable acute care competitors as well as a difficult payor environment. SCH's level of governmental and supplemental payor exposure remains a credit concern, though Fitch notes a robust advocacy strategy has helped preserve supplemental revenues and more timely reimbursement from the state to date. SCH expects to receive approximately $27 million in Medicare disproportionate share hospital (DSH), safety net designation, Medicaid high-volume DSH, and net Illinois provider assessment payments in fiscal 2016, compared to $28 million in fiscal 2015.

Going forward, Fitch believes SCH's designation as a safety net provider coupled with its steady market position should help stabilize revenue through the near term. Further, SCH's ambulatory and service line growth strategy, its work to position its clinical enterprise for value-based reimbursement, and its robust advocacy efforts will also help support operating stability.

DEBT PROFILE

Post issuance, SCH's total debt will remain near $180 million, with a 66% fixed-to-variable mix. SCH expects to fully refund its $92 million in fixed-rate series 2010A bonds and $13 million in fixed-rate series 2010C privately placed bonds with the series 2016 issuance. MADS is estimated at $12.4 million and debt service is largely level through maturity. SCH produced 4.12x coverage and had 209.4 DCOH per its June 30 2016 covenant calculations based on the OG. SCH also has $49.5 million in series 2008A variable-rate demand bonds are supported with a letter of credit which expires Oct. 31, 2017, $8.3 million in series 2011A variable-rate privately placed debt (not rated) and a $12.6 million fixed-rate new market tax credit loan (not rated).

SCH has approximately $118.4 million in notional swaps outstanding, which effectively fix SCH's variable-rate debt mix to 90%. With a $7.5 million collateral posting threshold, SCH had posted $7.4 million in collateral as of Sept. 30, 2016.

DISCLOSURE

SCH covenants to disclose annual financial information within 150 days of each fiscal year end and quarterly information within 60 days of each fiscal quarter end to the Municipal Securities Rulemaking Board's EMMA system. Fitch reports that SCH has provided consistent disclosure with very good access to management.

Additional information is available at 'www.fitchratings.com'.

Applicable Criteria

Revenue-Supported Rating Criteria (pub. 16 Jun 2014)
https://www.fitchratings.com/site/re/750012

U.S. Nonprofit Hospitals and Health Systems Rating Criteria (pub. 09 Jun 2015)
https://www.fitchratings.com/site/re/866807

Additional Disclosures

Dodd-Frank Rating Information Disclosure Form
https://www.fitchratings.com/creditdesk/press_releases/content/ridf_frame.cfm?pr_id=1013550

Solicitation Status
https://www.fitchratings.com/gws/en/disclosure/solicitation?pr_id=1013550

Endorsement Policy
https://www.fitchratings.com/regulatory

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTPS://WWW.FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEB SITE AT WWW.FITCHRATINGS.COM. PUBLISHED RATINGS, CRITERIA, AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE, AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE CODE OF CONDUCT SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

Copyright © 2016 by Fitch Ratings, Inc., Fitch Ratings Ltd. and its subsidiaries. 33 Whitehall Street, NY, NY 10004. Telephone: 1-800-753-4824, (212) 908-0500. Fax: (212) 480-4435. Reproduction or retransmission in whole or in part is prohibited except by permission. All rights reserved. In issuing and maintaining its ratings and in making other reports (including forecast information), Fitch relies on factual information it receives from issuers and underwriters and from other sources Fitch believes to be credible. Fitch conducts a reasonable investigation of the factual information relied upon by it in accordance with its ratings methodology, and obtains reasonable verification of that information from independent sources, to the extent such sources are available for a given security or in a given jurisdiction. The manner of Fitch’s factual investigation and the scope of the third-party verification it obtains will vary depending on the nature of the rated security and its issuer, the requirements and practices in the jurisdiction in which the rated security is offered and sold and/or the issuer is located, the availability and nature of relevant public information, access to the management of the issuer and its advisers, the availability of pre-existing third-party verifications such as audit reports, agreed-upon procedures letters, appraisals, actuarial reports, engineering reports, legal opinions and other reports provided by third parties, the availability of independent and competent third- party verification sources with respect to the particular security or in the particular jurisdiction of the issuer, and a variety of other factors. Users of Fitch’s ratings and reports should understand that neither an enhanced factual investigation nor any third-party verification can ensure that all of the information Fitch relies on in connection with a rating or a report will be accurate and complete. Ultimately, the issuer and its advisers are responsible for the accuracy of the information they provide to Fitch and to the market in offering documents and other reports. In issuing its ratings and its reports, Fitch must rely on the work of experts, including independent auditors with respect to financial statements and attorneys with respect to legal and tax matters. Further, ratings and forecasts of financial and other information are inherently forward-looking and embody assumptions and predictions about future events that by their nature cannot be verified as facts. As a result, despite any verification of current facts, ratings and forecasts can be affected by future events or conditions that were not anticipated at the time a rating or forecast was issued or affirmed.

The information in this report is provided “as is” without any representation or warranty of any kind, and Fitch does not represent or warrant that the report or any of its contents will meet any of the requirements of a recipient of the report. A Fitch rating is an opinion as to the creditworthiness of a security. This opinion and reports made by Fitch are based on established criteria and methodologies that Fitch is continuously evaluating and updating. Therefore, ratings and reports are the collective work product of Fitch and no individual, or group of individuals, is solely responsible for a rating or a report. The rating does not address the risk of loss due to risks other than credit risk, unless such risk is specifically mentioned. Fitch is not engaged in the offer or sale of any security. All Fitch reports have shared authorship. Individuals identified in a Fitch report were involved in, but are not solely responsible for, the opinions stated therein. The individuals are named for contact purposes only. A report providing a Fitch rating is neither a prospectus nor a substitute for the information assembled, verified and presented to investors by the issuer and its agents in connection with the sale of the securities. Ratings may be changed or withdrawn at any time for any reason in the sole discretion of Fitch. Fitch does not provide investment advice of any sort. Ratings are not a recommendation to buy, sell, or hold any security. Ratings do not comment on the adequacy of market price, the suitability of any security for a particular investor, or the tax-exempt nature or taxability of payments made in respect to any security. Fitch receives fees from issuers, insurers, guarantors, other obligors, and underwriters for rating securities. Such fees generally vary from US$1,000 to US$750,000 (or the applicable currency equivalent) per issue. In certain cases, Fitch will rate all or a number of issues issued by a particular issuer, or insured or guaranteed by a particular insurer or guarantor, for a single annual fee. Such fees are expected to vary from US$10,000 to US$1,500,000 (or the applicable currency equivalent). The assignment, publication, or dissemination of a rating by Fitch shall not constitute a consent by Fitch to use its name as an expert in connection with any registration statement filed under the United States securities laws, the Financial Services and Markets Act of 2000 of the United Kingdom, or the securities laws of any particular jurisdiction. Due to the relative efficiency of electronic publishing and distribution, Fitch research may be available to electronic subscribers up to three days earlier than to print subscribers.

For Australia, New Zealand, Taiwan and South Korea only: Fitch Australia Pty Ltd holds an Australian financial services license (AFS license no. 337123) which authorizes it to provide credit ratings to wholesale clients only. Credit ratings information published by Fitch is not intended to be used by persons who are retail clients within the meaning of the Corporations Act 2001

Contacts

Fitch Ratings
Primary Analyst
Emily Wadhwani, +1-312-368-3347
Director
Fitch Ratings, Inc.
70 W. Madison Street
Chicago, IL 60602
or
Secondary Analyst
Mark Pascaris, +1-312-368-3135
Director
or
Committee Chairperson
Joanne Ferrigan, +1-212-908-0723
Senior Director
or
Media Relations, New York
Elizabeth Fogerty, +1-212-908-0526
elizabeth.fogerty@fitchratings.com

Contacts

Fitch Ratings
Primary Analyst
Emily Wadhwani, +1-312-368-3347
Director
Fitch Ratings, Inc.
70 W. Madison Street
Chicago, IL 60602
or
Secondary Analyst
Mark Pascaris, +1-312-368-3135
Director
or
Committee Chairperson
Joanne Ferrigan, +1-212-908-0723
Senior Director
or
Media Relations, New York
Elizabeth Fogerty, +1-212-908-0526
elizabeth.fogerty@fitchratings.com